Prevention of progression of Parkinson's disease with antioxidative therapy
Identifieur interne :
001233 ( PascalFrancis/Corpus );
précédent :
001232;
suivant :
001234
Prevention of progression of Parkinson's disease with antioxidative therapy
Auteurs : J. D. Grimes ;
M. N. Hassan ;
J. H. ThakarSource :
-
Progress in neuro-psychopharmacology and biological psychiatry [ 0278-5846 ] ; 1988.
RBID : Pascal:88-0359060
Descripteurs français
English descriptors
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
| A01 | 01 | 1 | | @0 0278-5846 |
|---|
| A02 | 01 | | | @0 PNPPD7 |
|---|
| A03 | | 1 | | @0 Prog. neuro-psychopharmacol. biol. psychiatry |
|---|
| A05 | | | | @2 12 |
|---|
| A06 | | | | @2 2-3 |
|---|
| A08 | 01 | 1 | ENG | @1 Prevention of progression of Parkinson's disease with antioxidative therapy |
|---|
| A11 | 01 | 1 | | @1 GRIMES (J. D.) |
|---|
| A11 | 02 | 1 | | @1 HASSAN (M. N.) |
|---|
| A11 | 03 | 1 | | @1 THAKAR (J. H.) |
|---|
| A14 | 01 | | | @1 Ottawa civic hosp., Parkinson's disease clin. lab. @2 Ottawa ON K1Y 4E9 @3 CAN @Z A11011000 |
|---|
| A20 | | | | @1 165-172 |
|---|
| A21 | | | | @1 1988 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 CNRS @2 17544 |
|---|
| A44 | | | | @0 0000 |
|---|
| A45 | | | | @0 4 p. |
|---|
| A47 | 01 | 1 | | @0 88-0359060 |
|---|
| A60 | | | | @1 P @2 C |
|---|
| A61 | | | | @0 A |
|---|
| A64 | | 1 | | @0 Progress in neuro-psychopharmacology and biological psychiatry |
|---|
| A66 | 01 | | | @0 GBR |
|---|
| C02 | 01 | X | | @0 002B02B06 |
|---|
| C03 | 01 | X | FRE | @0 Parkinson maladie |
|---|
| C03 | 02 | X | FRE | @0 Etiopathogénie |
|---|
| C03 | 03 | X | FRE | @0 Neurone dopaminergique |
|---|
| C03 | 04 | X | FRE | @0 Autooxydation |
|---|
| C03 | 05 | X | FRE | @0 Radical libre |
|---|
| C03 | 06 | X | FRE | @0 Antioxydant |
|---|
| C03 | 07 | X | FRE | @0 Chimiothérapie |
|---|
| C03 | 15 | X | FRE | @0 Système nerveux pathologie |
|---|
| C03 | 16 | X | FRE | @0 Traitement |
|---|
| C03 | 01 | X | ENG | @0 Parkinson disease |
|---|
| C03 | 02 | X | ENG | @0 Etiopathogenesis |
|---|
| C03 | 03 | X | ENG | @0 Dopaminergic neuron |
|---|
| C03 | 04 | X | ENG | @0 Autoxidation |
|---|
| C03 | 05 | X | ENG | @0 Free radical |
|---|
| C03 | 06 | X | ENG | @0 Antioxidant |
|---|
| C03 | 07 | X | ENG | @0 Chemotherapy |
|---|
| C03 | 15 | X | ENG | @0 Nervous system diseases |
|---|
| C03 | 16 | X | ENG | @0 Treatment |
|---|
| C03 | 01 | X | SPA | @0 Parkinson enfermedad |
|---|
| C03 | 02 | X | SPA | @0 Etiopatogenia |
|---|
| C03 | 03 | X | SPA | @0 Neurona dopaminérgica |
|---|
| C03 | 04 | X | SPA | @0 Autooxidación |
|---|
| C03 | 05 | X | SPA | @0 Radical libre |
|---|
| C03 | 06 | X | SPA | @0 Antioxidante |
|---|
| C03 | 07 | X | SPA | @0 Quimioterapia |
|---|
| C03 | 15 | X | SPA | @0 Sistema nervioso patología |
|---|
| C03 | 16 | X | SPA | @0 Tratamiento |
|---|
| N21 | | | | @1 826 |
|---|
| N82 | | | | @1 NBS |
|---|
|
|---|
| pR |
| A30 | 01 | 1 | ENG | @1 Canadian college of neuro-psychopharmacology. Annual meeting. 10 @3 Ottawa ON @4 1987 |
|---|
|
|---|
Format Inist (serveur)
| NO : | PASCAL 88-0359060 INIST |
|---|
| ET : | Prevention of progression of Parkinson's disease with antioxidative therapy |
|---|
| AU : | GRIMES (J. D.); HASSAN (M. N.); THAKAR (J. H.) |
|---|
| AF : | Ottawa civic hosp., Parkinson's disease clin. lab./Ottawa ON K1Y 4E9/Canada (A11011000) |
|---|
| DT : | Publication en série; Congrès; Niveau analytique |
|---|
| SO : | Progress in neuro-psychopharmacology and biological psychiatry; ISSN 0278-5846; Coden PNPPD7; Royaume-Uni; Da. 1988; Vol. 12; No. 2-3; Pp. 165-172; Bibl. 4 p. |
|---|
| LA : | Anglais |
|---|
| CC : | 002B02B06 |
|---|
| FD : | Parkinson maladie; Etiopathogénie; Neurone dopaminergique; Autooxydation; Radical libre; Antioxydant; Chimiothérapie; Système nerveux pathologie; Traitement |
|---|
| ED : | Parkinson disease; Etiopathogenesis; Dopaminergic neuron; Autoxidation; Free radical; Antioxidant; Chemotherapy; Nervous system diseases; Treatment |
|---|
| SD : | Parkinson enfermedad; Etiopatogenia; Neurona dopaminérgica; Autooxidación; Radical libre; Antioxidante; Quimioterapia; Sistema nervioso patología; Tratamiento |
|---|
| LO : | CNRS-17544 |
|---|
| ID : | 88-0359060 |
|---|
Links to Exploration step
Pascal:88-0359060
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Prevention of progression of Parkinson's disease with antioxidative therapy</title>
<author><name sortKey="Grimes, J D" sort="Grimes, J D" uniqKey="Grimes J" first="J. D." last="Grimes">J. D. Grimes</name>
</author><author><name sortKey="Hassan, M N" sort="Hassan, M N" uniqKey="Hassan M" first="M. N." last="Hassan">M. N. Hassan</name>
</author><author><name sortKey="Thakar, J H" sort="Thakar, J H" uniqKey="Thakar J" first="J. H." last="Thakar">J. H. Thakar</name>
</author><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">88-0359060</idno>
<date when="1988">1988</date>
<idno type="stanalyst">PASCAL 88-0359060 INIST</idno>
<idno type="RBID">Pascal:88-0359060</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001233</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Prevention of progression of Parkinson's disease with antioxidative therapy</title>
<author><name sortKey="Grimes, J D" sort="Grimes, J D" uniqKey="Grimes J" first="J. D." last="Grimes">J. D. Grimes</name>
</author><author><name sortKey="Hassan, M N" sort="Hassan, M N" uniqKey="Hassan M" first="M. N." last="Hassan">M. N. Hassan</name>
</author><author><name sortKey="Thakar, J H" sort="Thakar, J H" uniqKey="Thakar J" first="J. H." last="Thakar">J. H. Thakar</name>
</author><series><title level="j" type="main">Progress in neuro-psychopharmacology and biological psychiatry</title>
<title level="j" type="abbreviated">Prog. neuro-psychopharmacol. biol. psychiatry</title>
<idno type="ISSN">0278-5846</idno>
<imprint><date when="1988">1988</date>
</imprint><seriesStmt><title level="j" type="main">Progress in neuro-psychopharmacology and biological psychiatry</title>
<title level="j" type="abbreviated">Prog. neuro-psychopharmacol. biol. psychiatry</title>
<idno type="ISSN">0278-5846</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antioxidant</term>
<term>Autoxidation</term>
<term>Chemotherapy</term>
<term>Dopaminergic neuron</term>
<term>Etiopathogenesis</term>
<term>Free radical</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Etiopathogénie</term>
<term>Neurone dopaminergique</term>
<term>Autooxydation</term>
<term>Radical libre</term>
<term>Antioxydant</term>
<term>Chimiothérapie</term>
<term>Système nerveux pathologie</term>
<term>Traitement</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0278-5846</s0>
</fA01><fA02 i1="01"><s0>PNPPD7</s0>
</fA02><fA03 i2="1"><s0>Prog. neuro-psychopharmacol. biol. psychiatry</s0>
</fA03><fA06><s2>2-3</s2>
</fA06><fA08 i1="01" i2="1" l="ENG"><s1>Prevention of progression of Parkinson's disease with antioxidative therapy</s1>
</fA08><fA11 i1="01" i2="1"><s1>GRIMES (J. D.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>HASSAN (M. N.)</s1>
</fA11><fA11 i1="03" i2="1"><s1>THAKAR (J. H.)</s1>
</fA11><fA14 i1="01"><s1>Ottawa civic hosp., Parkinson's disease clin. lab.</s1>
<s2>Ottawa ON K1Y 4E9</s2>
<s3>CAN</s3>
<sZ>A11011000</sZ>
</fA14><fA20><s1>165-172</s1>
</fA20><fA21><s1>1988</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>CNRS</s1>
<s2>17544</s2>
</fA43><fA44><s0>0000</s0>
</fA44><fA45><s0>4 p.</s0>
</fA45><fA47 i1="01" i2="1"><s0>88-0359060</s0>
</fA47><fA60><s1>P</s1>
<s2>C</s2>
</fA60><fA64 i2="1"><s0>Progress in neuro-psychopharmacology and biological psychiatry</s0>
</fA64><fA66 i1="01"><s0>GBR</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Etiopathogénie</s0>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Neurone dopaminergique</s0>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Autooxydation</s0>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Radical libre</s0>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Antioxydant</s0>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Chimiothérapie</s0>
</fC03><fC03 i1="15" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC03><fC03 i1="16" i2="X" l="FRE"><s0>Traitement</s0>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Etiopathogenesis</s0>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Dopaminergic neuron</s0>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Autoxidation</s0>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Free radical</s0>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Antioxidant</s0>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Chemotherapy</s0>
</fC03><fC03 i1="15" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC03><fC03 i1="16" i2="X" l="ENG"><s0>Treatment</s0>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Etiopatogenia</s0>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Neurona dopaminérgica</s0>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Autooxidación</s0>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Radical libre</s0>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Antioxidante</s0>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Quimioterapia</s0>
</fC03><fC03 i1="15" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC03><fC03 i1="16" i2="X" l="SPA"><s0>Tratamiento</s0>
</fC03><fN21><s1>826</s1>
</fN21><fN82><s1>NBS</s1>
</fN82><pR><fA30 i1="01" i2="1" l="ENG"><s1>Canadian college of neuro-psychopharmacology. Annual meeting. 10</s1>
<s3>Ottawa ON</s3>
<s4>1987</s4>
</fA30><server><NO>PASCAL 88-0359060 INIST</NO>
<ET>Prevention of progression of Parkinson's disease with antioxidative therapy</ET>
<AU>GRIMES (J. D.); HASSAN (M. N.); THAKAR (J. H.)</AU>
<AF>Ottawa civic hosp., Parkinson's disease clin. lab./Ottawa ON K1Y 4E9/Canada (A11011000)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Progress in neuro-psychopharmacology and biological psychiatry; ISSN 0278-5846; Coden PNPPD7; Royaume-Uni; Da. 1988; Vol. 12; No. 2-3; Pp. 165-172; Bibl. 4 p.</SO>
<LA>Anglais</LA>
<CC>002B02B06</CC>
<FD>Parkinson maladie; Etiopathogénie; Neurone dopaminergique; Autooxydation; Radical libre; Antioxydant; Chimiothérapie; Système nerveux pathologie; Traitement</FD>
<ED>Parkinson disease; Etiopathogenesis; Dopaminergic neuron; Autoxidation; Free radical; Antioxidant; Chemotherapy; Nervous system diseases; Treatment</ED>
<SD>Parkinson enfermedad; Etiopatogenia; Neurona dopaminérgica; Autooxidación; Radical libre; Antioxidante; Quimioterapia; Sistema nervioso patología; Tratamiento</SD>
<LO>CNRS-17544</LO>
<ID>88-0359060</ID>
</server>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001233 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001233 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:88-0359060
|texte= Prevention of progression of Parkinson's disease with antioxidative therapy
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
